DEC 23, 2018 11:22 PM PST

Preventive Drug Decreases Cases of Leprosy in Morocco

WRITTEN BY: Nouran Amin

Leprosy, also known as Hansen disease, is a disabling chronic and infectious disease that affects the skin and the peripheral nerves. It has a huge effect on public health of communities and nations as a whole. Since 1981, the introduction of antibacterial multidrug therapy has significantly decreased cases of leprosy on a worldwide scale. However, some countries like Morocco continue to have transmission of leprosy until the implementation of a new program.

Learn more about leprosy:

Now, cases of leprosy has declined in Morocco by more than 16 percent since 2012. This decline is due to the introduction of program involving a preventative drug according to a report published in PLOS Neglected Tropical Diseases. The drug involves a single dose of rifampicin and was introduced through the Single Dose Rifampicin Chemoprophylaxis (SDRC) program with the goal of decreasing the spread of leprosy through household contacts.

The leprosy cases were analyzed each year between 2000 and 2017 with data involving age, gender, origin, region, and grade of disability of leprosy patients. Results show that between 2000 and 2012, before the SDRC program, the leprosy cases was -4.68% per year. Now, between 2012 and 2017--after implementing SDRC the annual percent change per year was -16.83%.

Outpatients department. Kenitra Hospital.

Credit: Mary Gillham Archive Project, Flickr, CC BY 2.0, 2017 via MedicalXpress

"This time series can be of interest for the medical community as the authors analyze the trends in leprosy in the last 17 years and try to generate a hypothesis about any relationship with chemoprophylaxis implementation," the researchers say.

Source: MedicalXpress

About the Author
  • Nouran enjoys writing on various topics including science & medicine, global health, and conservation biology. She hopes through her writing she can make science more engaging and communicable to the general public.
You May Also Like
OCT 13, 2019
Cell & Molecular Biology
OCT 13, 2019
Stopping Metastasis After Breast Cancer Surgery
Cancer is most deadly when it metastasizes, which can happen after tumor-removal surgery. It's a serious challenge for many patients....
OCT 13, 2019
Drug Discovery & Development
OCT 13, 2019
Novel Drug Target for Dilating Microvessels
Medical scientists at Augusta University have discovered a natural occurring chemical that dilates blood vessels dilate as well as signaling larger blood v...
OCT 13, 2019
Cancer
OCT 13, 2019
Cancer drugs don't work the way we thought
New research recently published in the journal Science Translational Medicine surprises the oncological community with findings that a protein previously t...
OCT 13, 2019
Drug Discovery & Development
OCT 13, 2019
Leukemia Drug Effective for Treating Childhood Brain Cancer
Scientists at the University of California-San Diego have found that a chronic myeloid leukemia drug was found to treat medulloblastoma in mouse models mor...
OCT 13, 2019
Drug Discovery & Development
OCT 13, 2019
AI Exponentially Accelerates Drug Development
Research and development for new drugs is both an expensive and lengthy process, often lasting years, if not decades. With the development of artificial in...
OCT 13, 2019
Genetics & Genomics
OCT 13, 2019
Non-Invasive Gene Therapy Holds Promise for Treating Blindness
Researchers at John Hopkins Medicine have found a way to deliver sight-saving gene therapy to the retina. Having already shown success in treating rates, p...
Loading Comments...